Ignite Creation Date:
2025-12-25 @ 4:34 AM
Ignite Modification Date:
2026-01-17 @ 11:18 AM
Study NCT ID:
NCT01786018
Status:
UNKNOWN
Last Update Posted:
2014-07-08
First Post:
2013-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas
Sponsor:
Azienda Ospedaliera San Giovanni Battista
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2015-02
Completion Date Type:
ESTIMATED
First Submit Date:
2013-02-05
First Submit QC Date:
None
Study First Post Date:
2013-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-07
Last Update Post Date:
2014-07-08
Last Update Post Date Type:
ESTIMATED